We evaluated interactions between the VEGF SNPs significantly associated with bladder cancer risk and other determinants of risk (i.e., age, gender, smoking status, family history of cancer in at least one first-degree relative, and NAT2 and GSTM1 genotypes). The gene discussed is GSTM1; the disease is urinary bladder carcinoma.